Close Menu

Is Judge Robert Sweet's decision to overturn Myriad's BRCA1 and BRCA2 gene patents the end of gene patenting as we know it? Genomics Law Report's John Conley and Dan Vorhaus broke down the case and its implications in their blog, saying it is an important decision, but it is equally important not to overstate things.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.